Risk Intelligence
Commodity inflation may outpace price hikes
View Risks →Apollo Tyres reported a strong Q4 FY26 with consolidated revenue of ₹7,340 crore (+14% YoY) and EBITDA margin of 14.6% (+160bps YoY).
✓ Verified against BSE filing
Apollo Tyres reported a strong Q4 FY26 with consolidated revenue of ₹7,340 crore (+14% YoY) and EBITDA margin of 14.6% (+160bps YoY). India operations drove growth with high-teens volume growth in replacement and OE, while Europe remained muted with revenue down 1% YoY. The company announced a ₹3,500 crore capex for FY27, with 80% towards capacity expansion. However, raw material costs are expected to rise mid-to-high teens sequentially in Q1 FY27, prompting price hikes of 6-8% already announced, with more needed. The closure of the Enschede plant is on track, with a non-cash write-off of €43 million. Key risk: sustained commodity inflation could pressure margins if price hikes lag, especially given volatile geopolitical conditions in West Asia.
अपोलो टायर्स ने वित्त वर्ष 2026 की चौथी तिमाही में मजबूत प्रदर्शन किया। कंपनी की कुल कमाई ₹7,340 करोड़ रही, जो पिछले साल से 14% ज्यादा है। कमाई पर खर्च घटाने के बाद बचत (EBITDA मार्जिन) 14.6% रही, जो पिछले साल से 1.6% बेहतर है। भारत में बिक्री तेजी से बढ़ी, जबकि यूरोप में कमाई 1% घटी। कंपनी ने अगले साल ₹3,500 करोड़ का निवेश करने की योजना बनाई है, जिसमें 80% क्षमता बढ़ाने पर खर्च होगा। लेकिन कच्चे माल की कीमतें बढ़ने वाली हैं, इसलिए कंपनी ने 6-8% कीमतें बढ़ाने का ऐलान किया है। एनशेडे प्लांट बंद करने का काम जारी है, जिससे €43 करोड़ का गैर-नकद घाटा होगा। मुख्य जोखिम: अगर कीमतें नहीं बढ़ाई गईं तो मुनाफा कम हो सकता है, खासकर पश्चिम एशिया में अस्थिरता के कारण।
Commodity inflation may outpace price hikes
View Risks →Full transcript text is available on this route.
Read Transcript →India revenue grew 14.3% YoY to ₹5,240 crore, driven by strong volume growth in replacement and OE.
Europe revenue declined 1% YoY due to muted market conditions and supply issues from India.
Capacity utilization remained high at 90% across India and Europe, limiting ability to meet demand.
Net debt to EBITDA improved from 3.2x to 0.4x, reflecting strong cash flow and deleveraging.
Price increases of 6-8% announced for Q1 FY27, with at least two more rounds required to offset raw material cost inflation.
Positive impact on European margins expected from H2 FY27 after Enschede closure and stabilization.
Raw material costs expected to increase mid-to-high teens in Q1 FY27 vs Q4 FY26, with further pressure possible in Q2.
Capex of ₹3,500 crore planned for FY27, with nearly 80% allocated to capacity expansion in India and Hungary.
Board approved ₹5,800 crore capex for expanding PCR and TBR capacities at the Andhra plant, spread over three financial years.
Elevated A&P spend in Q3 (₹150 crore) will normalize to about 2.5% of sales in a steady state from FY27 onwards.
Raw material costs rising mid-to-high teens sequentially, with only 6-8% price hikes announced; further increases needed but timing uncertain.
Geopolitical developments add uncertainty to raw material, energy, and logistics costs, potentially impacting margins further.
Analyst raised concern that price hikes and diesel price increases could impact fleet operator profitability and demand in H2 FY27.
Closure of Enschede plant may result in loss of agricultural tire OE business, estimated at ~5% of Europe revenue.
International commodity prices and currency fluctuations could increase raw material costs, pressuring margins. Management noted flattish outlook but acknowledged unpredictability.
Q3 A&P spend was ₹150 crore (elevated due to BCCI sponsorship activation), and Q4 will also be high, delaying margin normalization to FY27.
European market growth was negative (-4% for PCR), and recovery is uncertain, limiting topline growth in that region.
The ₹5,800 crore capex over FY27-29 will increase debt and depreciation, potentially delaying RoCE improvement towards the 15% target.
Capex of ₹3,500 crore planned for FY27, with nearly 80% allocated to capacity expansion in India and Hungary.
Raw material costs rising mid-to-high teens sequentially, with only 6-8% price hikes announced; further increases needed but timing uncertain.
View Risks →